DK1677772T3 - Oral antidepressiv formulering, der indeholder acetylsalicylsyre, med henblik på acceleration af virkningens indtræden - Google Patents

Oral antidepressiv formulering, der indeholder acetylsalicylsyre, med henblik på acceleration af virkningens indtræden

Info

Publication number
DK1677772T3
DK1677772T3 DK03770801T DK03770801T DK1677772T3 DK 1677772 T3 DK1677772 T3 DK 1677772T3 DK 03770801 T DK03770801 T DK 03770801T DK 03770801 T DK03770801 T DK 03770801T DK 1677772 T3 DK1677772 T3 DK 1677772T3
Authority
DK
Denmark
Prior art keywords
acetylsalicylic acid
onset
action
antagonists
antidepressant
Prior art date
Application number
DK03770801T
Other languages
Danish (da)
English (en)
Inventor
Philippe Kriwin
De Tenbossche Roland Powis
Julien Mendlewicz
Original Assignee
Philippe Kriwin
De Tenbossche Roland Powis
Julien Mendlewicz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Philippe Kriwin, De Tenbossche Roland Powis, Julien Mendlewicz filed Critical Philippe Kriwin
Application granted granted Critical
Publication of DK1677772T3 publication Critical patent/DK1677772T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
DK03770801T 2003-10-29 2003-10-29 Oral antidepressiv formulering, der indeholder acetylsalicylsyre, med henblik på acceleration af virkningens indtræden DK1677772T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/BE2003/000181 WO2005039545A1 (en) 2003-10-29 2003-10-29 Oral antidepressant formulation comprising acetylsalicylic acid to accelerate onset of action

Publications (1)

Publication Number Publication Date
DK1677772T3 true DK1677772T3 (da) 2009-12-21

Family

ID=34468654

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03770801T DK1677772T3 (da) 2003-10-29 2003-10-29 Oral antidepressiv formulering, der indeholder acetylsalicylsyre, med henblik på acceleration af virkningens indtræden

Country Status (15)

Country Link
EP (1) EP1677772B1 (zh)
JP (1) JP2007509838A (zh)
CN (1) CN1859901A (zh)
AT (1) ATE440597T1 (zh)
AU (1) AU2003280232A1 (zh)
BR (1) BR0318586A (zh)
CA (1) CA2543640C (zh)
CY (1) CY1110572T1 (zh)
DE (1) DE60329034D1 (zh)
DK (1) DK1677772T3 (zh)
EA (1) EA011926B1 (zh)
ES (1) ES2332176T3 (zh)
PT (1) PT1677772E (zh)
SI (1) SI1677772T1 (zh)
WO (1) WO2005039545A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100189797A1 (en) * 2002-06-10 2010-07-29 Julien Mendlewicz Oral antidepressant formulation
IT1392333B1 (it) * 2008-12-16 2012-02-28 Giofarma S R L Preparazione farmaceutica per il trattamento di patologie depressive, contenente una proteina con elevato rapporto triptofano/lnaa
GB201002530D0 (en) 2010-02-15 2010-03-31 Univ Wolverhampton The Di-aspirin derivatives
CN112438991B (zh) * 2019-08-29 2024-03-15 鲁南制药集团股份有限公司 肝素、或其衍生物、或其可药用盐的医药用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650789A (en) * 1985-10-15 1987-03-17 Commonwealth Medical Corporation Of America Method and composition for increasing production of serotonin
GB2287404A (en) * 1994-03-15 1995-09-20 Pfizer Antiinflammatory and analgesic compositions
AU1718400A (en) * 1998-11-13 2000-06-05 Eli Lilly And Company Method for treating pain
EP1165083A2 (en) * 1999-04-06 2002-01-02 Sepracor Inc. Methods and compositions for the treatment of psychotic and related disorders using ziprasidone metabolites
US6432989B1 (en) * 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
WO2003103643A1 (en) * 2002-06-10 2003-12-18 Philippe Kriwin Oral antidepressant formulation comprising a selective serotonin_reuptake inhibitor

Also Published As

Publication number Publication date
CY1110572T1 (el) 2015-04-29
DE60329034D1 (de) 2009-10-08
EA200600834A1 (ru) 2006-10-27
EP1677772A1 (en) 2006-07-12
CA2543640C (en) 2010-06-01
EA011926B1 (ru) 2009-06-30
ES2332176T3 (es) 2010-01-28
CN1859901A (zh) 2006-11-08
BR0318586A (pt) 2006-10-17
ATE440597T1 (de) 2009-09-15
JP2007509838A (ja) 2007-04-19
SI1677772T1 (sl) 2010-01-29
WO2005039545A1 (en) 2005-05-06
AU2003280232A1 (en) 2005-05-11
CA2543640A1 (en) 2005-05-06
PT1677772E (pt) 2009-11-26
EP1677772B1 (en) 2009-08-26

Similar Documents

Publication Publication Date Title
PA8546601A1 (es) Nuevos derivados de indol con afinidad por el receptor 5-ht6
MXPA04000456A (es) Analogos de prostaglandina como agonistas del receptor ep4.
ATE406360T1 (de) Antagonisten der opioidrezeptoren
TW200635897A (en) Piperidine derivatives and their use as anti-inflammatory agents
EA200600190A1 (ru) Производные пиримидин-2,4-диона в качестве антагонистов рецептора гонадотропин-высвобождающего гормона
IS8503A (is) Azatvíhringja heteróhringir sem kannabínóníð-viðtakastillar
EA200970704A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ АНТАГОНИСТЫ NK1 РЕЦЕПТОРА И БЛОКАТОРЫ Na КАНАЛОВ
DE60302157D1 (de) Opioidrezeptorantagonisten
IS8377A (is) Arýlindenópyridín og arýlindenópyrimidín og notkun þeirra sem mótlyf A2A viðtaka adenósíns
DE69903333T2 (de) Crf rezeptor-antagonisten und darauf bezogene methoden
EA200400280A1 (ru) Новые неочищенные и кристаллические формы гидрохлорида лерканидипина
CY1110572T1 (el) Στοματικο αντικαταθλιπτικο σκευασμα το οποιο περιλαμβανει ακετυλοσαλικυλικο οξυ για επιταχυνση της εναρξης δρασης
AR037611A1 (es) Compuestos derivados de amino-tetralina, su uso, un procedimiento para su preparacion y composiciones farmaceuticas que los comprenden
NO20014855L (no) N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister
AR030788A1 (es) Antagonistas de receptores de taquiquinina zwitterionica
RS50764B (sr) Farmaceutska kompozicija koja uključuje so mirtazapina
EA200500672A1 (ru) Содержащие альфузозин композиции с отсроченным высвобождением
NO20035148D0 (no) Tri- og tetra-aza-acenaftylenderivater som CRF- reseptorantagonister
ATE384066T1 (de) Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren
MXPA05011476A (es) Imidazolin-2-il-aminofenil-amidas como antagonistas de prostaglandina i2.
RS56104A (en) Imidazoquinoline derivatives
DE60100811D1 (de) Crf rezeptor-antagonisten und darauf bezogene methoden
ATE260918T1 (de) Crf rezeptor-antagonisten und darauf bezogene methoden
WO2003103643A8 (en) ANTI-DEPRESSIVE ORAL ADMINISTRATION FORMULATION CONTAINING A SELECTIVE SEROTONIN REABSORPTION INHIBITOR
EA200401617A1 (ru) Комбинация nmda-антагониста и ингибиторов ацетилхолинэстеразы для лечения болезни альцгеймера